In AD, we found that VIM expression levels are elevated compared with healthy samples (Figure 4E) and that the difference is greater in younger compared with older individuals both at the protein level (Figure 4F) and at the transcript level in a larger cohort of samples (Supplementary Figure S11A). Here, VIM is linked to Alzheimer disease.